Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance. [electronic resource]
- Cancer immunology, immunotherapy : CII Jan 2016
- 47-59 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1432-0851
10.1007/s00262-015-1774-5 doi
Histocompatibility Antigens Class I--immunology Humans Immunotherapy--methods Male Neoplasm Recurrence, Local Prostatic Neoplasms--immunology beta 2-Microglobulin--immunology